<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0050">
 <label>50</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Lai</surname>
    <given-names>MJ</given-names>
   </string-name>, 
   <string-name>
    <surname>Ojha</surname>
    <given-names>R</given-names>
   </string-name>, 
   <string-name>
    <surname>Lin</surname>
    <given-names>MH</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>1-arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase</article-title>. 
  <source>Eur J Med Chem</source>
  <year>2019</year>;
  <volume>162</volume>:
  <fpage>612</fpage>–
  <lpage>30</lpage>.
  <pub-id pub-id-type="pmid">30476825</pub-id>
 </mixed-citation>
</ref>
